Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US11299532B2 · kind B2 · utility

7Cited by
67References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 29, 2021
Grant dateApr 12, 2022
Priority date
Expiry dateSep 29, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising anti-VEGF proteins and methods for producing such compositions in chemically defined media to reduce amounts of certain Aflibercept variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.